COVID-19 vaccination in Kazakhstan

COVID-19 vaccination in Kazakhstan
Date1 February 2021 (2021-02-01) – present
CauseCOVID-19 pandemic in Kazakhstan

COVID-19 vaccination in Kazakhstan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Background and timeline

Following the COVID-19 outbreak in Kazakhstan, the Director General of the National Center for Biotechnology Erlan Ramanqūlov in April 2020 announced the stages on developing the COVID-19 vaccine, stressing that clinical trials usually take up to 10 years to develop and that all verified research process would be cut short due to intense situation in the country, making the vaccine against coronavirus be produced usually faster and would be available to the public within next year and a half.[1]

In May 2020, the Ministry of Education and Science reported that the preclinical trials for the COVID-19 vaccine had begun of which was developed by the employees of the Research Institute of Biological Safety Problems of the Science Committee under the Ministry by the strain of the coronavirus isolated from patients and that the World Health Organization (WHO) had registered the vaccine development.[2] At the cabinet meeting, Education and Science Minister Ashat Aimagambetov announced that five COVID-19 vaccines were being developed and that the preclinical trials would be tested on animals until September 2020, when the clinical stages would begin for humans.[3]

Kazakhstan has created its own COVID-19 vaccination, QazCovid-in, developed by the Research Institute for Biological Safety Problems.[4] On 7 April 2021, the Healthcare Minister Alexey Tsoi announced that the Kazakh government had requested 4 million doses of Russia's Sputnik V vaccine, in addition to 2 million doses already received earlier in 2021, as part of an ongoing vaccination programme alongside QazCovid-in.[5]

In October 2021, the first Kazakh vaccine to protect cats from COVID-19, NARUVAX-C19, was unveiled at the Kazagro/Kazfarm-2021 international exhibition. [6]

Vaccine in order

Sputnik VGreen check.svg YesGreen check.svg Yes
QazCovid-inGreen check.svg YesGreen check.svg Yes
Sinopharm BIBP[7]Green check.svg YesGreen check.svg Yes
Sinovac[8]Green check.svg YesGreen check.svg Yes
Sputnik Light[9]Green check.svg YesDark Red x.svg No
QazCoVac-PDark Red x.svg NoDark Red x.svg No


  1. ^ "Названы сроки создания вакцины против COVID-19 в Казахстане - Новости Казахстана и мира на сегодня". (in Russian). April 17, 2020. Retrieved July 15, 2021.
  2. ^ "В Казахстане начали доклинические испытания вакцины от коронавируса - Аналитический интернет-журнал Vласть". (in Russian). May 18, 2020. Archived from the original on May 26, 2020. Retrieved July 15, 2021.
  3. ^ Дубовая, Мария (June 19, 2020). "Испытания казахстанской вакцины против коронавируса на людях планируют начать в сентябре". (in Russian). Archived from the original on July 24, 2020. Retrieved July 15, 2021.
  4. ^ Yergaliyeva, Aidana (December 20, 2020). "Kazakhstan Begins Vaccinating 3,000 Volunteers With Self-Made QazCovid-in". The Astana Times. Archived from the original on December 28, 2020. Retrieved April 7, 2021.
  5. ^ Reuters Staff (April 7, 2021). "Kazakhstan asks Russia for additional Sputnik V supplies". Reuters. Retrieved April 7, 2021.
  6. ^ October 2021, Saniya Bulatkulova in Society on 25 (October 25, 2021). "No Pet Left Behind! New NARUVAX-C19 Vaccine for Cats Unveiled in Nur-Sultan". The Astana Times. Retrieved December 8, 2021.
  7. ^ Satubaldina, Assel (April 30, 2021). "Three Vaccines to Become Available to Kazakh Citizens". The Astana Times. Archived from the original on April 30, 2021. Retrieved May 1, 2021.
  8. ^ "В Казахстан доставили первую партию китайской вакцины CoronaVac | Kazakhstan Today". (in Russian). Retrieved June 7, 2021.
  9. ^ "Kazakhstan approves Russia's single-dose Sputnik Light vaccine". Reuters. Moscow. July 15, 2021. Retrieved July 15, 2021.

Media files used on this page

Coronavirus. SARS-CoV-2.png
Author/Creator: Alexey Solodovnikov (Idea, Producer, CG, Editor), Valeria Arkhipova (Scientific Сonsultant), Licence: CC BY-SA 4.0
Scientifically accurate atomic model of the external structure of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), a strain (genetic variant) of the coronavirus that caused Coronavirus disease (COVID-19), first identified in Wuhan, China, during December 2019

Each separate locus (amorphous blob) is an atom of:

  cobalt: membrane
  crimson: E protein
  green: M protein
  orange: glucose (glycan)
  turquoise : S (spike) glycoprotein
SARS-CoV-2 (Wikimedia colors).svg
Author/Creator: Geraki, Licence: CC BY-SA 4.0
SARS-CoV-2 logo in Wikimedia colors
Green check.svg
Green check icon
Dark Red x.svg
Dark Red "X"/Cross logic icon.
SARS-CoV-2 (CDC-23312).png
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. This virus was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.